The United States Food and Drug Administration has said it was only taking “a closer look” as directed by President Donald Trump at the use of Chloroquine for the treatment of Coronavirus (COVID-19) and not that it had been approved.
President Trump had at a news conference on Thursday said the FDA had endorsed Chloroquine for the treatment of COVID-19.
FDA Commissioner, Stephen Hahn, who spoke after Trump’s media briefing on Thursday, said the access being granted falls under what is called “compassionate use.”
Hahn said: “If there is an experimental drug that is potentially available, a doctor could ask for that drug to be used in a patient.
“We have criteria for that and very speedy approval for that.
“As an example, many Americans have read studies and heard media reports about this drug chloroquine, which is an anti-malarial drug.
“It’s already approved, as the president said, for the treatment of malaria as well as an arthritis condition.
“That’s a drug that the president directed us to take a closer look at, as to whether an expanded use approach to that could be done to actually see if that benefits patients.”
The announcement follows encouraging research into chloroquine and hydroxychloroquine in France and China, but many in the wider scientific community have cautioned more work is needed to prove they really work for COVID-19.
Chloroquine is a synthetic form of quinine, which has been used to treat malaria since the 1940s.
Hydroxychloroquine shares a similar mechanism of action, but is less toxic.
French drug maker Sanofi on Wednesday said it stood ready to offer the French Government millions of doses of hydroxychloroquine, sold under its brand name: Plaquenil, in light of a “promising” study carried out by Didier Raoult of the IHU Mediterranee Infection in Marseille.
Raoult reported this week that after treating 24 patients for six days with Plaquenil, the virus had disappeared in all, but a quarter of them.
The research has not yet been peer reviewed and published.
Trending
- EFCC has adjusted its blunder, now claims Bello stole N80b within first three weeks in office — Media Office
- PDP Caucus extends Damagum’s tenure as acting Chairman
- Lagos reacts to allegation of Ministry’s refusal to shelter minor forced to have abortions
- AltBank, Sterling One Foundation, Lagos Foodbank combat hunger, champion education
- Nigerian professors jailed in Cameroon petition House of Reps
- Stanbic IBTC seeks way to maximise Nigeria’s energy potentials
- MOSOP speaks on Lagos-Calabar Coastal Highway
- Ondo 2024: Two nabbed for allegedly printing fake membership cards